CSIMarket
 


Sellas Life Sciences Group Inc   (SLS)
Other Ticker:  
 

Sellas Life Sciences Group Inc 's Tangible Leverage Ratio

SLS's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth


In III Quarter 2023 Sellas Life Sciences Group Inc had stockholder deficit.

Within Major Pharmaceutical Preparations industry Sellas Life Sciences Group Inc achieved the lowest Tangible Leverage Ratio in the third quarter 2023. While total ranking remained the same in the third quarter 2023 compared to the previous quarter at no. .

Explain Tangible Leverage Ratio?
What is SLS Market Share?
What are SLS´s Total Liabilities?


SLS Tangible Leverage Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Tangible Equity Change - -82.91 % 433.16 % -84.07 % -56.74 %
Y / Y Total Liabilities Change -14.6 % 4.33 % -8.47 % 180.84 % 20.16 %
Tangible Leverage Ratio MRQ - 4.69 1.42 5.48 1.25
SLS's Total Ranking # # # # #
Seq. Tangible Equity Change - -73.98 % 283.21 % -72.51 % -37.68 %
Seq. Total Liabilities Change -16.59 % -13.88 % -0.98 % 20.05 % 1.91 %



Tangible Leverage Ratio third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Tangible Leverage Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Sellas Life Sciences Group Inc 's Tangible Equity $ -6 Millions Visit SLS's Balance sheet
Sellas Life Sciences Group Inc 's Total Liabilities $ 11 Millions Visit SLS's Balance sheet
Source of SLS's Sales Visit SLS's Sales by Geography


Cumulative Sellas Life Sciences Group Inc 's Tangible Leverage Ratio

SLS's Tangible Leverage Ratio for the trailling 12 Months

SLS Tangible Leverage Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Tangible Equity TTM Growth - -82.91 % 433.16 % -84.07 % -56.74 %
Y / Y Total Liabilities TTM Growth -14.6 % 4.33 % -8.47 % 180.84 % 20.16 %
Tangible Leverage Ratio TTM 5.03 2.13 1.39 1.83 1.03
Total Ranking TTM
Seq. Tangible Equity TTM Growth - -73.98 % 283.21 % -72.51 % -37.68 %
Seq. Total Liabilities TTM Growth -16.59 % -13.88 % -0.98 % 20.05 % 1.91 %


On the trailing twelve months basis During the 12 months period ending III Quarter 2023 company had stockholder deficit.
Tangible Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry SLS recorded the lowest Tangible Leverage Ratio. While total ranking remained unchanged compared to previous 12 month period at no. 24.

Explain Tangible Leverage Ratio?
What is SLS Market Share?
What are SLS´s Total Liabilities?

TTM Tangible Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Within the Market #


trailing twelve months Tangible Leverage Ratio Statistics
High Average Low
0 0 0
 




Companies with similar Tangible Leverage Ratio in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Tangible Leverage RatioSep 30 2023 MRQ Total LiabilitiesSep 30 2023 MRQ Tangible Equity

Date modified: 2023-11-12T08:31:31+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com